Authors:

R. Noviyani

Abstract:

“Objective:Cervical cancer became Indonesia’s highest prevalent gynecological cancer in 2013 and the highest prevalent gynecological cancer at Sanglah Hospital.Paclitaxel Carboplatin is one of the regimens used for cervical cancer treatment at Sanglah Hospital, Denpasar. Aside of providing therapeutic effect, this regimen also causes hepatotoxicity. This research was trying to determine the toxic effect of Paclitaxel Carboplatin towards liver function based on the difference of SGOT and SGPT levels before chemotherapy cycle I and after chemotherapy cycle VI. Method:This wasa prospective observational research with a study case method conducted from January 2017 until June 2017 at Obstetric Polyclinic of Sanglah Hospital, Denpasar.Samples’ SGOT and SGPT level before and after chemotherapy I and VI were recorded and were then analysed with Shapiro-Wilk normality test. If the data were distributed normally, they would undergo tpaired test and Wilcoxon test at 95% confidence level if they were not distributed normally. Results: Tenpatients fulfilled the research criteria. There was a meaningless increase for SGOT level (p=0.575) along with a meaningless increase for SGPT level (p=0.074) before and after Paclitaxel Carboplatin chemotherapy cycle I and VI respectively.Conclusion: Research of toxic effect from Paclitaxel Carboplatin chemotherapy in 10 squamous cell cervical cancer patients showed a meaningless difference of both SGOT and SGPT level with the value of p>0.05 in stadium IIB-IIIB squamous cell cervical cancer patients before and after Paclitaxel Carboplatin chemotherapy cycle I and VI respectively.”

Keywords

Keyword Not Available

Downloads:

Download data is not yet available.

References

  • [1] GLOBOCAN. (2012). Cervical Cancer
  • Estimated Incidence, Mortality and
  • Prevalence Worldwide in 2012 [Online].
  • Lyon, France: International Agency for
  • Research on Cancer (IARC). Available:
  • http://globocan.iarc.
  • [2] Kemenkes RI. (2015a). Pusat Data
  • danInformasiKementrianKesehatan RI.
  • Jakarta: KementerianKesehatanRepublik
  • Indonesia
  • [3] Herfindal, E. T., and D. R. Gourley. (2000).
  • Textbook of Therapeutics Drugs and Disease
  • Management. USA: Lippincott Williams &
  • Wilkins.
  • [4] Wiebe, E. L. Denny, and G. Thomas. (2012).
  • Cancer of the Cervix Uteri.International
  • Journal of Gynecology and Obstetrics.
  • 119S2. pp. S100-S109.
  • [5] KomiteMedik RSUP Sanglah. (2011).
  • ProtokolKemoterapiOnkologiGinekologi.
  • Denpasar: RumahSakitUmumPusatSanglah.
  • [6] Chan, J. K., C. Tian, G. F. Fleming, B. J.
  • Monk, T. J. Herzog, D. S. Kapp, and J. Bell.
  • (2010). The Potential Benefit of 6 Vs 3
  • Cycles of Chemotherapy In Subsets of
  • Women with Early-Stage High-Risk
  • Epithelial Ovarian Cancer: An Exploratory
  • Analysis of a Gynecologic Oncology Group
  • Study. Gynecologic Oncology. 116. Pp. 301–
  • 306.
  • [7] Smith, I. E., M. E.R. O’Brien, D. C. Talbot,
  • M. C. Nicolson, J.L. Mansi, T. F. Hickish, et
  • al. (2001).Duration of Chemotherapy in
  • Advanced Non–Small-Cell Lung Cancer: A
  • Randomized Trial of Three Versus
  • SixCourses of Mitomycin, Vinblastine, and
  • Cisplatin. Journal of Clinical
  • Oncology.19(5).pp. 1336-1343.
  • [8] Sweetman, S. C. (2009).Martindale: The
  • Complete Drug Reference, Thirty-sixth
  • Edition. London: Pharmaceutical Press.
  • [9] Sumardjo, D. (2006). Pengantar Kimia
  • BukuPanduanKuliahMahasiswaKedokteran
  • dan Program Strata I FakultasBioeksata.
  • Jakarta: PenerbitBukuKedokteran EGC.
  • [10] Bastiyansyah, E.
  • (2008).PanduanLengkapMembacaTesKeseh
  • atan. Jakarta: Penebar Plus.
  • [11] Kemenkes RI. (2015b).
  • PanduanPelayananKlinisKankerServiks.

PDF:

https://jurnal.harianregional.com/jhsm/full-47791

Published

2018-02-02

How To Cite

NOVIYANI, R.. DIFFERENCE OF SGOT AND SGPT LEVEL IN STADIUM IIB-IIIB SQUAMOUS CELL CERVICAL CANCER PATIENTS BEFORE AND AFTER CHEMOTHERAPY AT SANGLAH HOSPITAL DENPASAR.Journal of Health Sciences and Medicine, [S.l.], v. 2, n. 1, p. 5, feb. 2018. ISSN 2622-0555. Available at: https://ojs.unud.ac.id/index.php/JHSM/article/view/47791. Date accessed: 28 Aug. 2025.

Citation Format

ABNT, APA, BibTeX, CBE, EndNote - EndNote format (Macintosh & Windows), MLA, ProCite - RIS format (Macintosh & Windows), RefWorks, Reference Manager - RIS format (Windows only), Turabian

Issue

Vol 2 No 1 (2018): JHSM (February 2018)

Section

Articles

Creative Commons License This work is licensed under a Creative Commons Attribution 4.0 International License